Latest filing published 16 Jun 2020 for Iterum Therapeutics plc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David George Kelly: trading record in brief
David George Kelly is a declared insider at 2 companies; the most frequent names are Iterum Therapeutics plc and Horizon Therapeutics Public Ltd Co. Between 23 March 2016 and 13 June 2020, the trades on record add up to 5 filings.
The open-market record is one-sided, with 1 purchase worth €55k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 option exercises.
Most recently, on 16 June 2020, the filings show an option exercise in Iterum Therapeutics plc. The clock since the last published purchase (4 December 2018) now reads 2,897 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David George Kelly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,406 sharesOrdinary SharesSEC:0000899243-20-016644:0
- 6,154 sharesOrdinary SharesSEC:0000899243-19-015011:0
- 10,000 shares@ US$6.29Ordinary SharesSEC:0001209191-18-060998:0Canonical exit: 28 Feb 2019 (T+90)
- 9,548 sharesOrdinary SharesSEC:0001209191-18-034200:0
- 19,250 sharesOrdinary SharesSEC:0001209191-16-110485:0
5 of 5 declarations